Dr. Patrick Soon-Shiong Shares Promising Results of Novel Adenoviral Colon Cancer Vaccine in Treating End-Stage Colon Cancer

Dr. Patrick Soon-Shiong CEO of NantWorks and founder of Cancer Breakthroughs 2020, announced that a novel genetically engineered adenovirus vaccine designed to treat colon cancer showed, in Phase II testing, a more than doubling of survival rate, with little to no toxicity. Promising results show some patients alive now more than five years after receiving the colon vaccine while on no other therapy.

Read full press release here.